...
首页> 外文期刊>Infection >Kinetics and Quantification of Antibacterial Effects of Beta-Lactams, Macrolides, and Quinolones against Gram-Positive and Gram-Negative RTI Pathogens.
【24h】

Kinetics and Quantification of Antibacterial Effects of Beta-Lactams, Macrolides, and Quinolones against Gram-Positive and Gram-Negative RTI Pathogens.

机译:动力学和定量的β-内酰胺,大环内酯类和喹诺酮类药物对革兰氏阳性和革兰氏阴性RTI病原体的抗菌作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Traditionally, the in vitro activity of antibacterial agents is characterized by their minimal inhibitory concentrations. However, these endpoints are, by nature, discrete and do not provide information on time-dependent killing of the bacteria during the incubation period. Nevertheless, the pharmacodynamic characteristics of antibacterial agents are almost always defined by correlating a static endpoint describing the antibacterial activity of an agent with the pharmacokinetics, describing the time-dependent fluctuation of drug concentrations. This approach is basically a contradiction in itself. Therefore, it would be more logical to correlate pharmacokinetics to in vitro parameters describing the time- and concentration-dependent antibacterial action of an agent. Thus, experimental methods and mathematical models quantifying the decrease in growth rate of a bacterial population due to the action of an antibacterial agent as a function of time and drug concentration have been applied to quantitate their pharmacodynamics. The effect of nine antibacterial agents representing drug classes of penicillins, cephalosporins, penems, macrolides, and fluoroquinolones were mathematically analyzed by using three different but related models. The kill rate, maximal kill, the 50%-effective concentration (EC(50)), the Hill coefficient, and concentrations and times needed to obtain a 1,000-fold decrease of the initial number of viable counts were calculated. Both the phenotypic description of the time-kill curves and these five parameters mirror the bacteriostatic or bactericidal activity of all nine agents studied as a function of time and concentration. Therefore, it would be more logical to correlate a parameter quantifying the kinetics of antibacterial in vitro activity with the pharmacokinetics of the drug, thus, replacing static endpoints like minimal inhibitory concentrations.
机译:传统上,抗菌剂的体外活性以其最小抑制浓度为特征。但是,这些端点本质上是离散的,并且不提供有关孵育期间细菌的时间依赖性杀灭的信息。然而,几乎总是通过将描述药物的抗菌活性的静态终点与描述药物浓度随时间变化的药代动力学相关联的静态终点来定义抗菌药物的药效特性。这种方法本质上本身就是一个矛盾。因此,将药代动力学与描述试剂的时间和浓度依赖性抗菌作用的体外参数关联起来将更合乎逻辑。因此,已经应用了量化由于抗菌剂的作用而随时间和药物浓度而变化的细菌种群生长速率下降的实验方法和数学模型,以量化其药效学。通过使用三个不同但相关的模型,对代表青霉素,头孢菌素,青霉素,大环内酯类和氟喹诺酮类药物的9种抗菌剂的作用进行了数学分析。计算杀灭率,最大杀灭率,50%有效浓度(EC(50)),Hill系数,以及使存活计数的初始数量减少1,000倍所需的浓度和时间。时间杀灭曲线的表型描述和这五个参数都反映了所研究的全部九种药剂随时间和浓度变化的抑菌或杀菌活性。因此,将定量体外抗菌活性的动力学参数与药物的药代动力学相关联,从而替代诸如最小抑制浓度之类的静态终点,将是更合乎逻辑的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号